Cargando…

A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio

Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ningbo, Chen, Dongni, Zheng, Jiabo, Wen, Zhesheng, Lin, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536709/
https://www.ncbi.nlm.nih.gov/pubmed/31213896
http://dx.doi.org/10.2147/CMAR.S204938
_version_ 1783421821002973184
author Fan, Ningbo
Chen, Dongni
Zheng, Jiabo
Wen, Zhesheng
Lin, Peng
author_facet Fan, Ningbo
Chen, Dongni
Zheng, Jiabo
Wen, Zhesheng
Lin, Peng
author_sort Fan, Ningbo
collection PubMed
description Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ(2)=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ(2)=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ(2)=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
format Online
Article
Text
id pubmed-6536709
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65367092019-06-18 A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio Fan, Ningbo Chen, Dongni Zheng, Jiabo Wen, Zhesheng Lin, Peng Cancer Manag Res Original Research Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ(2)=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ(2)=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ(2)=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Dove 2019-05-23 /pmc/articles/PMC6536709/ /pubmed/31213896 http://dx.doi.org/10.2147/CMAR.S204938 Text en © 2019 Fan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Fan, Ningbo
Chen, Dongni
Zheng, Jiabo
Wen, Zhesheng
Lin, Peng
A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title_full A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title_fullStr A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title_full_unstemmed A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title_short A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
title_sort novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536709/
https://www.ncbi.nlm.nih.gov/pubmed/31213896
http://dx.doi.org/10.2147/CMAR.S204938
work_keys_str_mv AT fanningbo anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT chendongni anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT zhengjiabo anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT wenzhesheng anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT linpeng anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT fanningbo novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT chendongni novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT zhengjiabo novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT wenzhesheng novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio
AT linpeng novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio